Template:Candida vulvovaginitis: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Mehdi Pahlavani moved page Template:Candidiasis to Template:Candida vulvovaginitis without leaving a redirect)
 
(12 intermediate revisions by 4 users not shown)
Line 3: Line 3:
| colspan="1" style="text-align:center; background:DarkGray" |
| colspan="1" style="text-align:center; background:DarkGray" |


'''Candidiasis Microchapters
'''Candida vulvovaginitis Microchapters'''
'''
|- bgcolor="LightGrey"
|- bgcolor="LightGrey"
!
!
Line 10: Line 9:
|- bgcolor="LightCoral"
|- bgcolor="LightCoral"
!
!
[[Candidiasis|Home]]
[[Candida vulvovaginitis|Home]]
|-  
|-  
!
!
Line 16: Line 15:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Candidiasis (patient information)|Patient Info]]
[[Candida vulvovaginitis (patient information)|Patient Information]]
|-  
|-  
|-  
|-  
Line 23: Line 22:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Candidiasis overview|Overview]]
[[Candida vulvovaginitis overview|Overview]]
|-  
|-  
!
!
Line 29: Line 28:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Candidiasis historical perspective|Historical perspective]]
[[Candida vulvovaginitis historical perspective|Historical Perspective]]
|-  
|-  
!
!
Line 35: Line 34:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Candidiasis pathophysiology|Pathophysiology]]
[[Candida vulvovaginitis classification|Classification]]
|-  
|-  
!
!
Line 41: Line 40:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Candidiasis epidemiology and demographics|Epidemiology and Demographics]]
[[Candida vulvovaginitis pathophysiology|Pathophysiology]]
|-  
|-  
!
!
Line 47: Line 46:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Candidiasis risk factors|Risk Factors]]
[[Candida vulvovaginitis causes|Causes]]
|-  
|-  
!
!
Line 53: Line 52:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Candidiasis screening|Screening]]
[[Candida vulvovaginitis differential diagnosis|Differentiating Candidiasis from other Diseases]]
|-  
|-  
!
!
Line 59: Line 58:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Candidiasis natural history, complications, and prognosis|Natural history, Complications, and Prognosis]]
[[Candida vulvovaginitis epidemiology and demographics|Epidemiology and Demographics]]
|-  
|-  
!
!
Line 65: Line 64:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Candidiasis classification|Classification]]
[[Candida vulvovaginitis risk factors|Risk Factors]]
|-  
|-  
!
!
Line 71: Line 70:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Candidiasis causes|Causes]]
[[Candida vulvovaginitis screening|Screening]]
|-  
|-  
!
!
Line 77: Line 76:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Candidiasis differential diagnosis|Differentiating Candidiasis from other Diseases]]
[[Candida vulvovaginitis natural history, complications and prognosis|Natural History, Complications and Prognosis]]
|-  
|-  
!
!
Line 89: Line 88:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Candidiasis history and symptoms|History and Symptoms]]
[[Candida vulvovaginitis history and symptoms|History and Symptoms]]
|-  
|-  
!
!
Line 95: Line 94:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Candidiasis physical examination|Physical Examination]]
[[Candida vulvovaginitis physical examination|Physical Examination]]
|-  
|-  
!
!
Line 101: Line 100:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Candidiasis laboratory findings|Laboratory Findings]]
[[Candida vulvovaginitis laboratory findings|Laboratory Findings]]
|-  
|-  
!
!
Line 107: Line 106:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Candidiasis electrocardiogram|Electrocardiogram]]
[[Candida vulvovaginitis x ray| X Ray]]
|-  
|-  
!
!
Line 113: Line 112:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Candidiasis chest x ray|Chest X Ray]]
[[Candida vulvovaginitis CT| CT]]
|-  
|-  
!
!
Line 119: Line 118:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Candidiasis MRI|MRI]]
[[Candida vulvovaginitis other imaging findings| Other Imagining Findings]]
|-  
|-  
!
!
Line 125: Line 124:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Candidiasis CT|CT]]
[[Candida vulvovaginitis other diagnostic studies|Other Diagnostic Studies]]
|-
!
 
|- bgcolor="LightSkyBlue"
!
[[Candidiasis echocardiography or ultrasound|Echocardiography or Ultrasound]]
|-
!
 
|- bgcolor="LightSkyBlue"
!
[[Candidiasis other imaging findings|Other Imaging Findings]]
|-
!
 
|- bgcolor="LightSkyBlue"
!
[[Candidiasis other diagnostic studies|Other Diagnostic Studies]]
|-  
|-  
!
!
Line 155: Line 136:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Candidiasis dietary management|Dietary Management]]
[[Candida vulvovaginitis medical therapy|Medical Therapy]]
|-  
|-  
!
!
Line 161: Line 142:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Candidiasis medical therapy|Medical Therapy]]
[[Candida vulvovaginitis surgery|Surgery]]
|-  
|-  
!
!  


|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Candidiasis surgery|Surgery]]
[[Candida vulvovaginitis primary prevention|Primary Prevention]]
|-  
|-  
!
!  


|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Candidiasis primary prevention|Primary Prevention]]
[[Candida vulvovaginitis secondary prevention|Secondary Prevention]]
|-  
|-  
!  
!  
Line 179: Line 160:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Candidiasis secondary prevention|Secondary Prevention]]
[[Candida vulvovaginitis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
|-  
|-  
!  
!  
Line 185: Line 166:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Candidiasis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
[[Candida vulvovaginitis future or investigational therapies|Future or Investigational Therapies]]
|-  
|-  
!  
!
 
|- bgcolor="CadetBlue"
!
Case Studies
|-
!


|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Candidiasis future or investigational therapies|Future or Investigational Therapies]]
[[Candida vulvovaginitis case study one|Case #1]]
|-  
|-
!  
!


|- bgcolor="PaleGoldenrod "
|- bgcolor="PaleGoldenrod "

Latest revision as of 15:41, 1 May 2017